Lexeo Therapeutics, Inc. (LXEO)
NASDAQ: LXEO · Real-Time Price · USD
9.23
+0.23 (2.56%)
At close: Oct 24, 2025, 4:00 PM EDT
9.37
+0.14 (1.52%)
After-hours: Oct 24, 2025, 7:27 PM EDT
Lexeo Therapeutics Analyst Ratings
Total Analysts
8
Consensus Rating
Strong Buy
Price Target
$18.13
Upside
+96.42%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $15 → $13 | Strong Buy | Maintains | $15 → $13 | +40.85% | Oct 21, 2025 |
| Guggenheim | Guggenheim | Strong Buy Initiates $30 | Strong Buy | Initiates | $30 | +225.03% | Oct 15, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $9 → $15 | Strong Buy | Maintains | $9 → $15 | +62.51% | Oct 7, 2025 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $15 → $17 | Strong Buy | Maintains | $15 → $17 | +84.18% | Oct 7, 2025 |
| Leerink Partners | Leerink Partners | Buy Maintains $9 → $20 | Buy | Maintains | $9 → $20 | +116.68% | Oct 7, 2025 |
| Leerink Partners | Leerink Partners | Buy Maintains $15 → $9 | Buy | Maintains | $15 → $9 | -2.49% | Aug 15, 2025 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $20 → $15 | Strong Buy | Maintains | $20 → $15 | +62.51% | Aug 15, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $15 → $9 | Strong Buy | Maintains | $15 → $9 | -2.49% | Aug 15, 2025 |
| Oppenheimer | Oppenheimer | Buy Initiates $20 | Buy | Initiates | $20 | +116.68% | Jul 31, 2025 |
| JP Morgan | JP Morgan | Buy Maintains $16 → $10 | Buy | Maintains | $16 → $10 | +8.34% | May 30, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $23 → $15 | Strong Buy | Maintains | $23 → $15 | +62.51% | May 16, 2025 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $22 → $20 | Strong Buy | Maintains | $22 → $20 | +116.68% | May 13, 2025 |
| Leerink Partners | Leerink Partners | Buy Maintains $18 → $16 | Buy | Maintains | $18 → $16 | +73.35% | May 12, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $23 | Strong Buy | Reiterates | $23 | +149.19% | Apr 8, 2025 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $25 → $22 | Strong Buy | Maintains | $25 → $22 | +138.35% | Apr 8, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $23 | Strong Buy | Reiterates | $23 | +149.19% | Mar 26, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.